YishengBio seeks greenlight for Hong Kong IPO

Jonathan Breen

March 09, 2021 07:45 am

China’s YishengBio is planning to list in Hong Kong, having filed an IPO application with the bourse on Monday.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs Health and Biotech Equity China Hong Kong SAR Asia Greater China Haitong Securities Morgan Stanley Northeast Asia Asia Pacific Emerging Markets SRI

JB

Jonathan Breen

Equities editor GlobalCapital Asia